Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Allergy Clinical Trials

A listing of Allergy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (24) clinical trials

Peanut Allergy Research Study for Children

Phase

A randomized, double-blind, superiority, multiple dose, placebo-controlled, parallel group, multi-centre, field study. A minimum of 1182 subjects will be randomized into the study, 394 in each of 2 active treatment groups and placebo group, at a ratio of 1:1:1. Subjects will be stratified in each of the treatment groups according ...

Phase

A new research study is being conducted for rhinitis (nasal congestion, runny nose, post-nasal drip, sneezing) or conjunctivitis (red, itchy, watery eyes) caused by dust mite allergies.

Phase

Do you love your cat but hate the allergies that follow?

Phase

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma

Phase

A Randomized, Double Blind, Double Dummy, Placebo Controlled, Parallel Group, 12 Week Clinical Study to Assess the Efficacy and Safety of 80 or 160 mcg/Day of Beclomethasone Dipropionate Delivered via Breath Actuated Inhaler (BAI) or Metered Dose Inhaler (MDI) in Pediatric Patients 5 Through 11 Years of Age with Persistent ...

Phase

Allergy study for adolescents ages 12 to 17 who are allergic to ragweed. Ragweed is a fall pollen. If you have allergy symptoms such as sneezing, runny or itchy nose, stuffy or congested nose, or itchy and watery eyes starting mid-August that last to the first frost, you could be ...

Phase

Does your child have Ragweeed Allergy or Hayfever? If so, your child may be eligible to participate in a research study of an investigational medication used to treat Allergies in children ages 4-17.

Phase

The objective of this study is to assess the efficacy and safety of 12 months of treatment with 300 IR of STG320 sublingual tablets compared with placebo in adults and adolescents with HDM-associated allergic rhinitis.

Phase

Study for individuals with a house dust mite allergy ages 12 to 65. Study medication is a tablet form of immunotherapy. Standard immunotherapy is allergy shots. This study does not use allergy shots, but is a sublingual tablet that dissolves under the tongue specific for dust mite allergy. Study lasts ...

Phase